Knockdown of ASCT2 in cancer cells impairs glutamine uptake and export, uptake of EAAs, and mTORC1 activation, which suggests that both uptake and export of glutamine are required for the activation of mTORC1 signaling [40,50]. The gene discussed is SLC1A5; the disease is cancer.